Avricore Health Secures $1.25M Private Placement to Address Going Concern
AVCRF has more than doubled off its 52-week low of $0.017.
Summary
Avricore Health announced a $1.25 million private placement at $0.05 per unit, including warrants, to fund operations and expansion following a recent going concern warning.
Key Events · Financing and Capital Events · AVCRF
-
$1.25 Million Private Placement Announced
The company is raising up to $1.25 million through a non-brokered private placement, issuing units at $0.05 each.
-
Significant Potential Dilution
The offering, including shares from units and associated warrants, could result in approximately 37% dilution to existing shareholders.
-
Addresses Going Concern Warning
This capital raise is vital for the company's survival, coming shortly after its auditor issued a going concern warning on May 8, 2026.
-
Warrant Terms Included
Each unit includes one common share and one-half transferable share purchase warrant, exercisable at $0.10 for 24 months.
Analysis · AVCRF · Life Sciences
Avricore Health Inc. announced a non-brokered private placement to raise up to $1.25 million by issuing units at $0.05 each. Each unit includes one common share and one-half warrant, with warrants exercisable at $0.10 for 24 months. This financing is critical for the company, especially following a recent going concern warning from its auditor. While the offering is highly dilutive, potentially increasing outstanding shares by approximately 37%, it provides essential capital for expanding the HealthTab™ network and for general working capital, which is crucial for the company's immediate operational viability.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVCRF was trading at $0.05 on OTC in the Life Sciences sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.02 to $0.08. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.